Records containing: Von Willebrand Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-11-07Phase II Clinical Efficacy Trial of Recombinant Interleukin-11 (rhIL-11, Neumega) in Women With Type 1 Von Willebrand Disease and Refractory Menorrhagia
-
CLINICAL_TRIALS study record update · 2014-11-07Phase II Clinical Efficacy Trial of Recombinant Interleukin-11 (rhIL-11, Neumega) in Subjects With Type 1 Von Willebrand Disease Undergoing Surgery
-
CLINICAL_TRIALS study record update · 2013-07-03Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador
-
CLINICAL_TRIALS study record update · 2013-05-06Changes in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle
-
CLINICAL_TRIALS study record update · 2011-09-30Does an Acquired Von Willebrand Syndrome Influence Perioperative Blood Loss in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement?
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-02-11Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjects With Von Willebrand's Disease.
-
CLINICAL_TRIALS study record update · 2011-02-11A Canadian, Multi-center, Prospective, Open-label, Observational, Pharmacovigilance Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced) in Patients Transitioning From Treatment With Currently Available Humate-P®
-
CLINICAL_TRIALS study record update · 2010-12-17Protocol for the Determination of Menstrual Blood Losses in Women Affected by Congenital Bleeding Disorders
-
CLINICAL_TRIALS study record update · 2010-04-26National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
-
CLINICAL_TRIALS study record update · 2010-03-03An Open Multi-centre Study to Investigate the Safety and Efficacy of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate, in Patients With Von Willebrand Disease Who Are Undergoing Surgery
-
CLINICAL_TRIALS study record update · 2010-03-03An Open Multi-centre Study in Patients With Von Willebrand Disease to Investigate the Pharmacokinetics, Efficacy and Safety of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate
-
CLINICAL_TRIALS study record update · 2009-08-21A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B
-
CLINICAL_TRIALS study record update · 2007-03-13Treatment and Management of Women With Bleeding Disorders